Amneal Pharmaceuticals, Inc. (AMRX) Current Federal Tax Expense (Benefit) USD 2016 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Amneal Pharmaceuticals, Inc. annual/quarterly Current Federal Tax Expense (Benefit) history and growth rate from 2016 to 2023.
  • Amneal Pharmaceuticals, Inc. Current Federal Tax Expense (Benefit) for the quarter ending March 27, 2020 was $110 M.
  • Amneal Pharmaceuticals, Inc. annual Current Federal Tax Expense (Benefit) for 2023 was $2.47 M.
  • Amneal Pharmaceuticals, Inc. annual Current Federal Tax Expense (Benefit) for 2022 was -$1.07 M, a 182% decline from 2021.
  • Amneal Pharmaceuticals, Inc. annual Current Federal Tax Expense (Benefit) for 2021 was $1.31 M.
Current Federal Tax Expense (Benefit), Annual (USD)
Current Federal Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.47 M +$3.54 M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 -$1.07 M -$2.38 M -182% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $1.31 M +$115 M Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 -$114 M -$111 M -4022% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-03
2019 -$2.76 M -$5.06 M -220% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $2.3 M +$2.3 M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $0 Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.